TCRT Stock Analysis: Buy, Sell, or Hold?
TCRT - Alaunos Therapeutics, Inc. Common Stock
$1.99
0.00 (0.00%)
â˛
5d:
+5.85%
30d:
-3.86%
90d:
-25.38%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
3d
Get Alerted When TCRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TCRT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TCRT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TCRT is currently trading at $1.99, which is considered fair relative to its 30-day fair value range of $1.92 to $2.10.
Technical Outlook: Technically, TCRT is in a strong downtrend. The price is approaching resistance at $2.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TCRT scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $1.75. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TCRT is in a strong downtrend. The price is approaching resistance at $2.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TCRT scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $1.75. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.92 -
$2.10
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 12.1% above Wall St target ($1.75)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.92 -
$2.10
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$2.02
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$1.75
(-12.1%)
Revenue Growth (YoY)
-25.0%
Share & Embed Analysis
Last updated: August 09, 2026 1:21 PM ET
Data refreshes hourly during market hours. Next update: 2:21 PM
Data refreshes hourly during market hours. Next update: 2:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 34 SELL |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 55 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 45 HOLD |
